Bortezomib Accord 3.5 mg, Pulver zur Herstellung einer lnjektionslösung - Swissmedic Key 67481002 Registration Holder Accord Healthcare AG Name Bortezomib Accord 3.5 mg, Pulver zur Herstellung einer lnjektionslösung Date of registration 06.03.2020 Original/Generic Generic Introduction of Sequence 06.03.2020 ATC-Classification Bortezomib (L01XG01) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 372.78 Limitation Yes Limitation text
Deductible 10 % Consumer price 421.85 Feedback FB GTIN 7680674810025 Medication Code Synthetika Pharmacode Disponibility
Composition bortezomibum 3.5 mg, mannitolum, pro vitro. Packungsbestandteile Galenic Form Pulver zur Herstellung einer lnjektionslösung Excipiens Active Agent Dose Bortezomib 3.5 mg
BAG: Active Agent Dose Bortezomib 3.5 mg
Source Data was imported : 07.06.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
